1. 3D.01: VISIT-TO-VISIT BLOOD PRESSURE VARIABILITY INCREASES RISK OF STROKE OR CARDIAC EVENTS IN PATIENTS GIVEN VALSARTAN OR AMLODIPINE IN THE VALUE TRIAL. (June 2015) Authors: Mehlum, M.; Liestøl, K.; Julius, S.; Kjeldsen, S.E.; Hua, T.A.; Rothwell, P.M.; Mancia, G.; Parati, G.; Weber, M.A.; Berge, E. Journal: Journal of hypertension Issue: Volume 33(2015)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. [OP.4A.01] SYSTOLIC VISIT-TO-VISIT BLOOD PRESSURE VARIABILITY INCREASES RISK OF MYOCARDIAL INFARCTION AND CONGESTIVE HEART FAILURE IN PATIENTS GIVEN VALSARTAN OR AMLODIPINE IN THE VALUE TRIAL. (September 2016) Authors: Mehlum, M.H.; Liestøl, K.; Julius, S.; Kjeldsen, S.E.; Hua, T.A.; Rothwell, P.M.; Mancia, G.; Parati, G.; Weber, M.A.; Berge, E. Journal: Journal of hypertension Issue: Volume 34:(2016) Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. [OP.8B.03] COFFEE IS A PREDICTOR OF FUTURE HYPERTENSION AND MICROALBUMINURIA IN TROPHY STUDY OF PREHYPERTENSION. (September 2017) Authors: Palatini, P.; Saladini, F.; Julius, S. Journal: Journal of hypertension Issue: Volume 35(2017)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. IMPORTANCE OF MEAN BLOOD PRESSURE AND BLOOD PRESSURE VARIABILITY FOR THE EFFECT OF VALSARTAN VERSUS AMLODIPINE ON CARDIOVASCULAR EVENTS AND DEATH. (June 2018) Authors: Mehlum, M. Hollund; Liestøl, K.; Kjeldsen, S.E.; Julius, S.; Hua, T.A.; Rothwell, P.M.; Weber, M.A.; Berge, E.; Mancia, G.; Parati, G. Journal: Journal of hypertension Issue: Volume 36(2018)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗